Hep DART 2021: Poster Presentations
Welcome to the poster portal for Hep DART 2021. All accepted abstracts are listed below for your viewing.
Please click on each abstract title to review the poster presentation which will open in a pop-up window.
If you have any questions regarding the presented data, please use the contact information provided for each presenting author to contact them.
The complete abstract booklet for Hep DART 2021 can be found here.
Ph-dependent interaction of NAPs with the HSP40 chaperone DnaJB12
Poster Abstract P1
Category: Hep DART
Presenter: Andrew Vaillant, Replicor Inc.
Contact: availlant@replicor.com
Long-acting entecavir prodrugs for HBV treatment
Poster Abstract P2
Category: Hep DART
Presenter: Anil Gupta, Calibr at Scripps Research
Contact: agupta@scripps.edu
Investigation of the anti-HBV activity of TL020 and its effects on host protein expression
Poster Abstract P3
Category: Hep DART
Presenter: Ryan Olsen, University of Nevada, Reno
Contact: rolsen@nevada.unr.edu
Treatment Intensification with Vebicorvir in Patients with Chronic Hepatitis B infection and Partial Virologic Suppression on Nucleos(t)ide Reverse Transcriptase Inhibitors
Poster Abstract P4
Category: Hep DART
Presenter: William Delaney, Assembly Bio
Contact: wdelaney@assemblybio.com
Novel dihydroquinolizinones for HBV surface antigen (HBsAg) reduction with liver targeting properties
Poster Abstract P5
Category: Hep DART
Presenter: Yanming Du, Baruch S Blumberg Institute
Contact: yanming.du@bblumberg.org
Therapeutic vaccination with the pre-S based vaccine VVX001 - interim analysis
Poster Abstract P6
Category: Hep DART
Presenter: Peter Ferenci
Contact: peter.ferenci@meduniwien.ac.at
Subcutaneous Administration of REP 2139-Mg in the Compassionate Treatment of Cirrhotic HBV / HDV Coinfection
Poster Abstract P7
Category: Hep DART
Presenter: Andrew Vaillant, Replicor Inc.
Contact: availlant@replicor.com
Mitochondrial stress in patients with chronic heptatis B and advanced fibrosis
Poster Abstract P8
Category: Hep DART
Presenter: Tarik Asselah, Hôpital Beaujon
Contact: tarik.asselah@aphp.fr
Hepatitis B virus infection and extra-hepatic manifestations: a systemic disease
Poster Abstract P9
Category: Hep DART
Presenter: Tarik Asselah, Hôpital Beaujon
Contact: tarik.asselah@aphp.fr
Electronic health engagement improves heptatis C care cascade in PWID
Poster Abstract P10
Category: Hep DART
Presenter: Arisha Baig, Austin Hepatitis Center
Contact: zohha.tariq@gmail.com
Response guided long-term treatment of chronic hepatitis D patients with bulevirtide - results of a “real world” study
Poster Abstract P11
Category: Hep DART
Presenter: Peter Ferenci
Contact: peter.ferenci@meduniwien.ac.at
The LIMT-2 study: a phase 3 study of 48-week treatment with peginterferon lambda in patients with chronichepatitis delta virus (HDV) infection
Poster Abstract P12
Category: Hep DART
Presenter: Ingrid Choong
Contact: ichoong@eigerbio.com
Increasing the performance of a fully automated, quantitative, assay for the detection of circulating HBV pregenomic RNA
Poster Abstract P13
Category: Hep DART
Presenter: Daniel McClernon, bioMONTR Labs
Contact: dmcclernon@biomontr.com